Hong Kong Pharmaceuticals & Biotech Most Popular Stocks

Nanjing Leads Biolabs

Market Cap: HK$12.7b

A clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide.

Alphamab Oncology

Market Cap: HK$12.3b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biotherapeutics for cancer treatment in the People’s Republic of China.

China Traditional Chinese Medicine Holdings

Market Cap: HK$12.0b

China Traditional Chinese Medicine Holdings Co.

HBM Holdings

Market Cap: HK$11.8b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$11.8b

A biotechnology company, engages in the research and development of novel antibody-based drugs in the People’s Republic of China, the United States, and internationally.

Shanghai Haohai Biological Technology

Market Cap: HK$11.7b

Shanghai Haohai Biological Technology Co., Ltd.

Abbisko Cayman

Market Cap: HK$11.6b

Engages in the research and development of pharmaceutical products in the People’s Republic of China and the European Union.

Ascletis Pharma

Market Cap: HK$11.4b

A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.

CStone Pharmaceuticals

Market Cap: HK$11.4b

A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally.

CARsgen Therapeutics Holdings

Market Cap: HK$10.7b

An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.

Shandong Xinhua Pharmaceutical

Market Cap: HK$10.1b

Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.

CK Life Sciences Int'l. (Holdings)

Market Cap: HK$8.7b

An investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America.

SSY Group

Market Cap: HK$8.7b

An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.

Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd

Market Cap: HK$8.2b

Engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China.

Shandong Boan Biotechnology

Market Cap: HK$8.1b

A biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China.

Beijing Tong Ren Tang Chinese Medicine

Market Cap: HK$7.4b

Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.

Jacobio Pharmaceuticals Group

Market Cap: HK$7.2b

An investment holding company, engages in the in-house discovery and development of oncology therapies.

Ocumension Therapeutics

Market Cap: HK$6.8b

Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.

Qyuns Therapeutics

Market Cap: HK$6.6b

A clinical-stage biotech company, engages in the research and development of biologic therapies for autoimmune and allergic diseases in the People’s Republic of China.

China Shineway Pharmaceutical Group

Market Cap: HK$6.1b

An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

Tong Ren Tang Technologies

Market Cap: HK$6.1b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

TYK Medicines

Market Cap: HK$6.0b

A clinical-stage biopharmaceutical company, research, development and commercialization of pharmaceutical products.

Viva Biotech Holdings

Market Cap: HK$5.4b

An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.

Laekna

Market Cap: HK$5.4b

An investing holding company, engages in the discovering, development, and commercialization of therapies for patients with cancer, metabolic diseases, and liver fibrosis in the People’s Republic of China, the United States of America, and South Korea.

AIM Vaccine

Market Cap: HK$5.1b

Engages in the research and development, manufacture, and sale of vaccine products for human use in the People’s Republic of China.

Beijing Luzhu Biotechnology

Market Cap: HK$4.9b

A biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China.

ImmuneOnco Biopharmaceuticals (Shanghai)

Market Cap: HK$4.5b

A biotechnology company, engages in the research and development of immuno-oncology therapies in the People’s Republic of China.

VISEN Pharmaceuticals

Market Cap: HK$4.4b

An investment holding company, engages in the development and commercialization of paradigm-shifting endocrine therapies in the Chinese Mainland.

Medtide

Market Cap: HK$4.3b

A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.

Antengene

Market Cap: HK$4.2b

A clinical-stage APAC biopharmaceutical company, develops novel oncology therapies in Greater China and internationally.

Cloudbreak Pharma

Market Cap: HK$4.0b

A clinical-stage ophthalmology biotechnology company, researches and develops ophthalmic drugs for chronic eye diseases.

Hua Medicine (Shanghai)

Market Cap: HK$3.9b

Engages in the development and commercialization of drugs for the treatment of diabetes in China.

Jiangsu Recbio Technology

Market Cap: HK$3.5b

A vaccine company, engages in the research, development, and commercialization of subunit vaccines in the People’s Republic of China.

Cutia Therapeutics

Market Cap: HK$3.1b

An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.

Mabpharm

Market Cap: HK$3.0b

A biopharmaceutical company, engages in research, development, production, and commercialization of drugs and biosimilar for cancers and autoimmune diseases in the People’s Republic of China.

Jacobson Pharma

Market Cap: HK$3.0b

Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.